雅虎香港 搜尋

登入

搜尋結果

  1. www.ncbi.nlm.nih.gov › pmc › articles4. A Novel Quadrivalent Inactivated Influenza Vaccine: ...

    2018年3月8日 · This review describes the results obtained from seven phase III clinical trials evaluating the immunogenicity, safety, and lot-to-lot consistency of a new quadrivalent split-virion influenza vaccine (Vaxigrip Tetra ®) formulated by adding a second B strain to the already licensed TIV.

    • Emanuele Montomoli, Alessandro Torelli, Ilaria Manini, Elena Gianchecchi
    • 10.3390/vaccines6010014
    • 2018
    • Vaccines (Basel). 2018 Mar; 6(1): 14.

  2. www.sanofi.com › assets › countriesPROFESSIONAL INFORMATION FOR VAXIGRIP TETRA - Sanofi

    VAXIGRIP TETRA is indicated for the prevention of influenza disease caused by the two influenza. virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age. and older,

  3. www.chp.gov.hk › tc › features衞生防護中心 - 季節性流感及肺炎球菌疫苗接種資訊 - Centre for ...

    季節性流感疫苗成分. 院舍防疫注射計劃在2015/16年度提供的疫苗包括以下成分： - 類甲型/加利福利亞/ 7/ 2009 (H1N1)pdm09病毒. - 類甲型/瑞士/9715293/2013 (H3N2) 病毒. - 類乙型/布吉/3073/2013病毒. - 類乙型/布利斯本/60/2008病毒. 院舍防疫注射計劃2015/16採用的是滅活流感疫苗。 建議劑量. 9歲或以上人士，每年都要接種一劑季節性流感疫苗。 為確保對季節性流感產生足夠的免疫力，凡9歲以下從未接種過季節性流感疫苗的兒童，建議應接種兩劑季節性流感疫苗，而兩劑疫苗的接種時間應至少相隔四個星期。 在2014/15年度或以前曾接種季節性流感疫苗的9歲以下兒童，在2015/16年度只需接種一劑疫苗。

  4. pubmed.ncbi.nlm.nih.gov › 29157068Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

    VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®).

    • Viviane Gresset-Bourgeois, Phillip S Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierr...
    • 2018

  5. www.tandfonline.com › doi › fullA trivalent, inactivated influenza vaccine (Vaxigrip®): ...

    2017年5月10日 · This quadrivalent formulation of Vaxigrip contains two A and two B influenza strains (VaxigripTetra), and has a similar immunogenicity and safety profile to the trivalent formulation while offering broader protection due to the addition of the second influenza B strain. KEYWORDS: Seasonal influenza. influenza vaccine.

    • Margaret Haugh, Viviane Gresset-Bourgeois, Bérengère Macabeo, Anne Woods, Sandrine I. Samson
    • 2017

  6. www.ncbi.nlm.nih.gov › pmc › articlesAn Advisory Committee Statement: Addendum to the 2010-2011 ...

    2011年9月9日 · NACI’s recommendations for the 2010-2011 season relate to use of four vaccines authorized in Canada that are formulated for intramuscular use: Fluviral ® (GlaxoSmithKline), Vaxigrip ® (Sanofi Pasteur), Agriflu ® (Novartis) and Influvac ® (Abbott).

  7. www.ktgh.com.tw › Medicament_tbDrug_Look【篤實 關懷 倫理 卓越】光田綜合醫院 Kuang Tien General Hospital

    VaxigripTetra尚無交互作用的研究，與其他疫苗同時接種的安全性資料尚未建立。依據Vaxigrip的臨床經驗，VaxigripTetra可以與其他疫苗同時接種。同時接種其他疫苗時，應使用不同注射器並於不同部位接種。 禁忌 對活性成分、章節6.1所列的任何賦形劑，或 ...